Market Value3,375,426,000
Total Holdings52
File Date2021-02-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ALEC / Alector, Inc.
GBT / Global Blood Therapeutics Inc. Call
US62857M1053 / MyoKardia, Inc.
MGTA / Magenta Therapeutics Inc
MASS / 908 Devices Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
FHTX / Foghorn Therapeutics Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
EXAS / Exact Sciences Corporation
RVMD / Revolution Medicines, Inc.
ADVM / Adverum Biotechnologies, Inc.
SGMO / Sangamo Therapeutics, Inc.
AGIO / Agios Pharmaceuticals, Inc.
IOVA / Iovance Biotherapeutics, Inc.
110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
BDTX / Black Diamond Therapeutics, Inc.
STOK / Stoke Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
GBIO / Generation Bio Co.
CCCC / C4 Therapeutics, Inc.
TSHA / Taysha Gene Therapies, Inc.
DYN / Dyne Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
AMRS / Amyris Inc Call
DCPH / Deciphera Pharmaceuticals, Inc.
TPTX / Turning Point Therapeutics Inc
US2103731061 / Constellation Pharmaceuticals Inc
ORIC / ORIC Pharmaceuticals, Inc.
BNR / Burning Rock Biotech Limited - Depositary Receipt (Common Stock)
FDMT / 4D Molecular Therapeutics, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
ALLO / Allogene Therapeutics, Inc.
AMRS / Amyris Inc
CDAK / Codiak Biosciences Inc
GBT / Global Blood Therapeutics Inc.
CDNA / CareDx, Inc
SEER / Seer, Inc.
BLI / Berkeley Lights Inc
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
ADPT / Adaptive Biotechnologies Corporation
CRSP / CRISPR Therapeutics AG
DMTK / DermTech, Inc.
TWST / Twist Bioscience Corporation
BLUE / bluebird bio, Inc.
BPMC / Blueprint Medicines Corporation
NVTA / Invitae Corporation
DNLI / Denali Therapeutics Inc.
ABCL / AbCellera Biologics Inc.
SNDX / Syndax Pharmaceuticals, Inc.
SRPT / Sarepta Therapeutics, Inc.
ILMN / Illumina, Inc.
PACB / Pacific Biosciences of California, Inc.
BEAM / Beam Therapeutics Inc.
KRON / Kronos Bio, Inc.
RLAY / Relay Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.
CDXS / Codexis, Inc.
BLFS / BioLife Solutions, Inc.